We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ebola Vaccine Trial Begins in Senegal

News   Jul 16, 2015

 
Ebola Vaccine Trial Begins in Senegal
 
 
Advertisement
 

RELATED ARTICLES

Chronic Sinusitis May Alter Brain Activity

News

New research links sinus inflammation with alterations in brain activity, specifically with the neural networks that modulate cognition, introspection and response to external stimuli.

READ MORE

Gut Bacteria's "Pep Talk" Enhances Horse's Athletic Performance

News

A horse's gut microbiome communicates with its host by sending chemical signals to its cells, which has the effect of helping the horse to extend its energy output, finds a new study. This exciting discovery paves the way for dietary supplements that could enhance equine athletic performance.

READ MORE

Oxford–AstraZeneca COVID-19 Vaccine: Regulators Give Update on Links to Rare Clotting Disorders

News

Dual announcements from regulators in the EU and the UK have jointly concluded that the Oxford–AstraZeneca vaccine, now trademarked as Vaxzevria, is effective at preventing COVID-19 and, overall, has benefits that outweigh any risk posed by extremely rare clotting disorders linked to the vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE